Federal Circuit Review | October 2025
October Federal Circuit Newsletter (Japanese) October Federal Circuit Newsletter (Chinese) Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing In US Inventor, Inc. v. United...
Federal Circuit Review | September 2025
September Federal Circuit Newsletter (Japanese) September Federal Circuit Newsletter (Chinese) Bait, Switch, and Retrial: Federal Circuit Rebukes Trial Arguments that Reneged on Prior Representations In Magēmā Technology LLC v....
Federal Circuit Review | August 2025
August Federal Circuit Newsletter (Japanese) August Federal Circuit Newsletter (Chinese) Deleted Specification Portions Undermine Claim Construction In FMC Corp. v. Sharda USA, LLC, Appeal No. 24-2335, the Federal Circuit...
Lawdragon Names 17 Knobbe Martens Partners Among ‘Leading Litigators in America’
IRVINE, Calif., September 8, 2025 – Knobbe Martens is pleased to share that 17 of the firm’s partners have been recognized in the 2026 edition of the Lawdragon 500 Leading...
Irfan Lateef and Ted Cannon Co-Author Piece on Notable Developments in IP Case Law for ABA
Knobbe Martens partners Irfan Lateef and Ted Cannon co-authored “Recent Developments in Intellectual Property Law 2025,” a chapter in the ABA Business and Corporate Law Section’s “Recent Developments in Business...
Knobbe Martens Partners Recognized as Top IP Strategists in 2025 IAM Strategy 300 Guide
IRVINE, Calif., August 14, 2025 – Knobbe Martens is pleased to share that a number of the firm’s partners have been recognized in the 2025 edition of the IAM Strategy...
Federal Circuit Review | July 2025
July Federal Circuit Newsletter (Japanese) July Federal Circuit Newsletter (Chinese) Combination Dosing Regimen Not Obvious Despite Overlapping Prior-Art Ranges In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Appeal...
Federal Circuit Review | June 2025
June Federal Circuit Newsletter (Japanese) June Federal Circuit Newsletter (Chinese) No Injury, No Appeal: Patent Owners Must Show Actual Injury for Article III Standing In Dolby Laboratories Licensing Corporation...
Federal Circuit Review | May 2025
May Federal Circuit Newsletter (Japanese) May Federal Circuit Newsletter (Chinese) Invoking the Hatch-Waxman Safe Harbor Does Not Necessarily Require Factual Development That Such Activities Fall Within its Scope In...
Knobbe Martens Celebrated as “Excellent IP Firm,” Dozens of Partners Recognized for Top-Tier Patent Work in IAM Patent 1000 Guide
IRVINE, Calif., June 3, 2025 – Knobbe Martens is pleased to share that the firm and two dozen of its partners from offices throughout the country have been featured in...
Federal Circuit Review | April 2025
April Federal Circuit Newsletter (Japanese) April Federal Circuit Newsletter (Chinese) Ready or Not, Here I Come: When Is a Trade Secret Publicly Accessible? In Ams-Osram USA Inc. v. Renesas...
Federal Circuit Review | March 2025
March Federal Circuit Newsletter (Japanese) March Federal Circuit Newsletter (Chinese) Limits of Inherent Anticipation in Product-by-Process Claims In Restem, LLC v. Jadi Cell, LLC, Appeal No. 23-2054, the Federal...
Federal Circuit Review | February 2025
February Federal Circuit Newsletter (Japanese) February Federal Circuit Newsletter (Chinese) Every Word Counts: Specification Naming Conventions Can Limit Claim Scope In HD Silicon Solutions LLC V. Microchip Technology Inc.,...
Fifteen Knobbe Martens Attorneys Recognized in Southern California Super Lawyers
IRVINE, Calif., February 20, 2025 – Knobbe Martens is pleased to share that a number of the firm’s attorneys have been recognized by Southern California Super Lawyers for their excellent...
Federal Circuit Review | January 2025
January Federal Circuit Newsletter (Japanese) January Federal Circuit Newsletter (Chinese) Motivation to Modify Under Obviousness Standard Does Not Need to Align with Patentee’s Goal In Honeywell International Inc. v....
In IAM Article, Knobbe Martens Partners Give Tips On IP Strategy For The Medical Device Industry
In the article “Capitalizing on Medical Device IP Opportunities in a Changing Environment,” published in Intellectual Asset Management’s latest special report on life sciences IP, partners Philip Nelson, Sabing Lee,...
Federal Circuit Review | December 2024
December Federal Circuit Newsletter (Japanese) December Federal Circuit Newsletter (Chinese) Bound to Happen: Inherent Property Leaves No Question of Reasonable Expectation of Success In Cytiva Bioprocess R&D Ab v....
Knobbe Martens Achieves Standout Ranking at 2024 Financial Times Innovative Lawyers North America Awards
IRVINE, Calif., December 11, 2024 – Knobbe Martens is honored to announce that the firm received a “Standout” recognition, the highest possible tier, in the Healthcare & Life Sciences category...
Federal Circuit Review | November 2024
November Federal Circuit Newsletter (Japanese) November Federal Circuit Newsletter (Chinese) Can’t Be Stopped: Appellants Cannot Dismiss Appeal Days Before a Mandate Issues In Cisco Systems, Inc. v. K.Mizra LLC,...
Irfan Lateef Named Among Business of Law Visionaries by Los Angeles Times
IRVINE, Calif., November 18, 2024 – Knobbe Martens is pleased to share that partner Irfan Lateef has been recognized as a 2024 Los Angeles Times Business of Law Visionary for...
Federal Circuit Review | October 2024
October 2024 Federal Circuit Newsletter (Japanese) October 2024 Federal Circuit Newsletter (Chinese) Failure to Obtain Advice of a Third Party Is Not Evidence of Willfulness In Provisur Technologies, Inc., v....
